DGRO vs VHT
iShares Core Dividend Growth ETF vs Vanguard Health Care ETF
- • DGRO has the lower expense ratio at 0.08% vs 0.09% for VHT.
- • DGRO pays a higher dividend yield (1.84%).
Side-by-side metrics
| Metric | DGRO | VHT |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.08% | 0.09% |
Dividend yield Trailing 12-month yield. | 1.84% | 1.35% |
AUM Assets under management — bigger funds are typically more liquid. | $45.26B | $23.73B |
YTD return | 18.79% | 22.17% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.61 | 0.46 |
P/E ratio | 21.59 | 32.41 |
Last price | $81.80 | $347.68 |
Inception | — | — |
Issuer | iShares | Vanguard |
DGRO top holdings
| XOM | ExxonMobil Holdings Corp | 3.33% |
| ABBV | AbbVie Inc | 3.05% |
| MSFT | Microsoft Corp | 3.04% |
| AAPL | Apple Inc | 3.04% |
| JNJ | Johnson & Johnson | 2.78% |
| JPM | JPMorgan Chase & Co | 2.66% |
| PG | Procter & Gamble Co | 2.42% |
| AVGO | Broadcom Inc | 2.40% |
| PM | Philip Morris International Inc | 2.27% |
| HD | The Home Depot Inc | 2.07% |
VHT top holdings
| LLY | Eli Lilly and Co | 12.93% |
| JNJ | Johnson & Johnson | 8.78% |
| ABBV | AbbVie Inc | 6.45% |
| MRK | Merck & Co Inc | 5.01% |
| UNH | UnitedHealth Group Inc | 4.65% |
| TMO | Thermo Fisher Scientific Inc | 3.50% |
| AMGN | Amgen Inc | 3.18% |
| GILD | Gilead Sciences Inc | 2.58% |
| ABT | Abbott Laboratories | 2.40% |
| PFE | Pfizer Inc | 2.27% |
About DGRO
DGRO (iShares Core Dividend Growth ETF) is US stocks with sustained dividend growth. Managed by iShares, the fund carries $45.3B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.84%. Its largest holding is ExxonMobil Holdings Corp (XOM), which represents 3.3% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 6.1%.
About VHT
VHT (Vanguard Health Care ETF) is US health care sector stocks. Managed by Vanguard, the fund carries $23.7B in assets under management, an expense ratio of 0.09%, a dividend yield of 1.35%. Its largest holding is Eli Lilly and Co (LLY), which represents 12.9% of the portfolio. Technology is the fund's largest sector exposure at 0.0%.